volume 20, issue 2, PS107-S110 1992
DOI: 10.1007/bf01705028
View full text
|
Sign up to set email alerts
|
Share

Abstract: This paper summarizes different theoretical and clinical approaches contributing to the concept of dose intensification. According to this concept, the amount of antineoplastic drug delivered per time predominantly determines the clinical outcome in patients with neoplastic disease. With the availability of recombinant haemopoietic growth factors haematotoxic side effects might be reduced, making this concept more feasible for clinical use. However, more prospective randomized studies, in which dose-intensity …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
1

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals